Nerve traffic recordings (muscle sympathetic nerve traffic [MSNA]) have shown that sympathetic activation may occur in obesity. However, the small sample size of the available studies, presence of comorbidities, heterogeneity of the subjects examined represented major weaknesses not allowing to draw definite conclusions. This is the case for the overweight state. The present meta-analysis evaluated 1438 obese or overweight subjects recruited in 45 microneurographic studies. The analysis was primarily based on MSNA quantification in obesity and overweight, excluding as concomitant conditions hypertension, metabolic syndrome, and other comorbidities. Assessment was extended to the relationships of MSNA with other neuroadrenergic markers, such as plasma norepinephrine and heart rate, anthropometric variables, as body mass index, waist-to-hip ratio, presence/absence of obstructive sleep apnea, and metabolic profile. Compared with normoweights MSNA was significantly greater in overweight and more in obese individuals (37.0±4.1 versus 43.2±3.5 and 50.4±5.0 burts/100 heartbeats, P<0.01). This was the case even in the absence of obstructive sleep apnea. MSNA was significantly directly related to body mass index and waist-to-hip ratio (r=0.41 and r=0.64, P<0.04 and <0.01, respectively), clinic blood pressure (r=0.68, P<0.01), total cholesterol, LDL (low-density lipoprotein) cholesterol, and triglycerides (r=0.91, r=0.94, and r=0.80, respectively, P<0.01) but unrelated to plasma insulin, glucose, and homeostatic model assessment for insulin resistance. No significant correlation was found between MSNA, heart rate, and norepinephrine. Thus, obesity and overweight are characterized by sympathetic overactivity which mirrors the severity of the clinical condition and reflects metabolic alterations, with the exclusion of glucose/insulin profile. Neither heart rate nor norepinephrine appear to represent faithful markers of the muscle sympathetic overdrive.

Grassi, G., Biffi, A., Seravalle, G., Trevano, F., Dell'Oro, R., Corrao, G., et al. (2019). Sympathetic Neural Overdrive in the Obese and Overweight State: Meta-Analysis of Published Studies. HYPERTENSION, 74(2), 349-358 [10.1161/HYPERTENSIONAHA.119.12885].

Sympathetic Neural Overdrive in the Obese and Overweight State: Meta-Analysis of Published Studies

Grassi, Guido
Primo
;
Biffi, Annalisa
Secondo
;
Seravalle, Gino;Trevano, Fosca Quarti;Dell'Oro, Raffaella;Corrao, Giovanni
Penultimo
;
Mancia, Giuseppe
Ultimo
2019

Abstract

Nerve traffic recordings (muscle sympathetic nerve traffic [MSNA]) have shown that sympathetic activation may occur in obesity. However, the small sample size of the available studies, presence of comorbidities, heterogeneity of the subjects examined represented major weaknesses not allowing to draw definite conclusions. This is the case for the overweight state. The present meta-analysis evaluated 1438 obese or overweight subjects recruited in 45 microneurographic studies. The analysis was primarily based on MSNA quantification in obesity and overweight, excluding as concomitant conditions hypertension, metabolic syndrome, and other comorbidities. Assessment was extended to the relationships of MSNA with other neuroadrenergic markers, such as plasma norepinephrine and heart rate, anthropometric variables, as body mass index, waist-to-hip ratio, presence/absence of obstructive sleep apnea, and metabolic profile. Compared with normoweights MSNA was significantly greater in overweight and more in obese individuals (37.0±4.1 versus 43.2±3.5 and 50.4±5.0 burts/100 heartbeats, P<0.01). This was the case even in the absence of obstructive sleep apnea. MSNA was significantly directly related to body mass index and waist-to-hip ratio (r=0.41 and r=0.64, P<0.04 and <0.01, respectively), clinic blood pressure (r=0.68, P<0.01), total cholesterol, LDL (low-density lipoprotein) cholesterol, and triglycerides (r=0.91, r=0.94, and r=0.80, respectively, P<0.01) but unrelated to plasma insulin, glucose, and homeostatic model assessment for insulin resistance. No significant correlation was found between MSNA, heart rate, and norepinephrine. Thus, obesity and overweight are characterized by sympathetic overactivity which mirrors the severity of the clinical condition and reflects metabolic alterations, with the exclusion of glucose/insulin profile. Neither heart rate nor norepinephrine appear to represent faithful markers of the muscle sympathetic overdrive.
Articolo in rivista - Articolo scientifico
body mass index; heart rate; insulin; norepinephrine; obesity;
body mass index; heart rate; insulin; norepinephrine; obesity
English
2019
74
2
349
358
reserved
Grassi, G., Biffi, A., Seravalle, G., Trevano, F., Dell'Oro, R., Corrao, G., et al. (2019). Sympathetic Neural Overdrive in the Obese and Overweight State: Meta-Analysis of Published Studies. HYPERTENSION, 74(2), 349-358 [10.1161/HYPERTENSIONAHA.119.12885].
File in questo prodotto:
File Dimensione Formato  
hypertension 2019.pdf

Solo gestori archivio

Tipologia di allegato: Publisher’s Version (Version of Record, VoR)
Dimensione 576.26 kB
Formato Adobe PDF
576.26 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/235924
Citazioni
  • Scopus 87
  • ???jsp.display-item.citation.isi??? 80
Social impact